Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
QuantumCyte, Inc. logo — Sample in. Clarity out.

QuantumCyte, Inc.

Sample in. Clarity out.

Founded 2013 United States Fremont, United States 15 employees Total: $1.05M Biotechnology, Life Sciences

General Information

Company Name QuantumCyte, Inc.
Founded Year 2013
Location United States Fremont, United States
Employees 15
Industries Biotechnology, Life Sciences
Business Model B2B, Platform, SaaS
Revenue Model Product Sales, Usage Based, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with QuantumCyte, Inc.. To contact QuantumCyte, Inc., visit quantumcyte.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does QuantumCyte, Inc. compare?

A PDF of QuantumCyte, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting QuantumCyte, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About QuantumCyte, Inc.

QuantumCyte, Inc., founded in 2013, is a transformative player in the Biotechnology and Life Sciences industries, headquartered in the United States. Their innovative approach bridges the gap between digital pathology, spatial biology, and molecular testing, promising to convert every biopsy into a rich source of insight.

With their flagship product, QCPRECISE, QuantumCyte, Inc. facilitates enhanced decision-making in research, diagnostics, and therapeutic development by converting image-based annotations into molecular clarity. This approach empowers stakeholders at every level to make faster and more confident decisions, addressing one of modern medicine's crucial needs.

The firm recently secured a $1.05M Early VC investment in August 2023. Their team's combined expertise in genomics, diagnostics, software engineering, and product development makes them a formidable player in advancing health technologies.

Business keywords: NextGen Microdissection Platform, technology platform company, in-situ lysis, automated tissue dissection system, digital tissue maps, ROIs, informative biomarkers, precision medicine, biopharma, NGS, Molecular Pathology, clinical diagnostics, spatial profiling

Services & Products

Tissue slide transformation
High-purity molecular sampling
Integrated precision diagnostics
AI-powered pathology integration

Target Customers

Research Labs Clinical Labs Pharmaceutical Companies Precision Medicine Innovators Healthcare Providers

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC $1.05M -
01 Aug 2023
Convertible Note Undisclosed 2
SOSV indiebio
SOSV, indiebio
01 Feb 2022
Convertible Note Undisclosed 2
SOSV indiebio
SOSV, indiebio
01 Jun 2021
Convertible Note Undisclosed -
01 Jun 2019
Convertible Note Undisclosed 2
SOSV indiebio
SOSV, indiebio
01 Mar 2018
Seed Undisclosed 2
SOSV indiebio
SOSV, indiebio
01 May 2017

QuantumCyte, Inc. Alternatives & Competitors

View All Alternatives
QuantumCyte, Inc. vs
HTG Molecular Diagnostics
HTG Molecular Diagnostics United States

HTG is focused on advancing precision medicine

Post-IPO Equity
33 employees
Biotechnology, Health Care
Compare QuantumCyte, Inc. vs HTG Molecular Diagnostics
QuantumCyte, Inc. vs
PredxBio
PredxBio United States

Reimagining Cancer Care with AI-Driven Spatial Biomarkers

Convertible Note
14 employees
AI, Biopharma
QuantumCyte, Inc. vs
Predicine
Predicine United States

Advancing precision medicine through next-generation liquid biopsy oncology platform

89 employees
Biotechnology, Health Care
View all alternatives

FAQ About QuantumCyte, Inc.

Sample in. Clarity out.
QuantumCyte, Inc. was founded in 2013.
QuantumCyte, Inc. is headquartered in Fremont, United States.
QuantumCyte, Inc. operates in Biotechnology and Life Sciences. Its work centres on NextGen Microdissection Platform, technology platform company, in-situ lysis and automated tissue dissection system. Its customers include Research Labs, Clinical Labs and Pharmaceutical Companies.
QuantumCyte, Inc. has a B2B, Platform and SaaS business model. Its revenue comes from Product Sales, Usage Based and Service Fee.
QuantumCyte, Inc. has approximately 15 employees.
QuantumCyte, Inc. has completed 6 funding rounds, raising a total of $1.05M.
QuantumCyte, Inc. offers: Tissue slide transformation, High-purity molecular sampling, Integrated precision diagnostics, AI-powered pathology integration.
Top alternatives and competitors to QuantumCyte, Inc. include HTG Molecular Diagnostics, PredxBio, Predicine, LCM Genect, Eurofins Genomics Americas. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
QuantumCyte, Inc. and HTG Molecular Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for QuantumCyte, Inc., https://bouncewatch.com/company/quantumcyte, updated 20 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes